Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:vaccine
|
| gptkbp:approvedBy |
malaria prevention
herpes zoster prevention |
| gptkbp:component |
adjuvant system AS01
|
| gptkbp:contains |
gptkb:QS-21
gptkb:MPL liposome |
| gptkbp:developedBy |
GlaxoSmithKline
|
| gptkbp:improves |
gptkb:immune_response
|
| gptkbp:introducedIn |
2010s
|
| gptkbp:mechanismOfAction |
TLR4 agonist activity
saponin-mediated immunostimulation |
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:usedIn |
gptkb:Shingrix_vaccine
RTS,S malaria vaccine |
| gptkbp:bfsParent |
gptkb:RTS,S/AS01_malaria_vaccine
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
AS01 adjuvant
|